DNA Damage is ceaseless. The latest in DNA Damage/Genotoxicity Kits, detects seven proteins in this pathway, including important phosphorylation changes. This white paper demonstrates the utility in two cancer cell lines in which all analytes were detected with good specificity, sensitivity and precision.

Researchers have developed a new machine learning technique that can track down beneficial mutations in population genetic datasets.

Brain immune system is key to recovery from motor neuron degeneration.

New technologies have allowed for the development of two complement panels, based on dilution factors, to determine levels of 15 key complement proteins simultaneously in serum or plasma.

A medical imaging technology under development has enabled doctors to see bacteria deep inside patients' lungs for the first time. Early tests indicate the bedside technology may be able to detect harmful bacteria in patients' lungs in less than 60 seconds.

A new assay has been developed that includes characteristic analytes for every cardiac disease stage. After rigorous assay validation, it was discovered that many of the CVD biomarkers were significantly elevated in CVD patients, indicating the utility of the assay panels.

Drug appears to reverse structural and genetic brain changes that affect memory, learning.

Priming the immune system with induced pluripotent stem cells prevented or slowed the development of cancer in mice, researchers have found.